Nettsider med emneord «pandemic»

The University of Oslo honours Grødeland for her exemplary efforts in conveying research-based knowledge about vaccines to the public. "It's important that we express exactly what we mean based on the facts we observe, and that we are not afraid to do so," says this year's winner.

An international research team seeks to examine the virus-host interaction of Marburg virus (MARV) and establish a blueprint for the targeted development of antiviral strategies for newly emerging viruses. Researcher Tuula Nyman leads UiOs contribution to the new EU project.

In the first 18 months of the pandemic Aotearoa New Zealand, a country of 5 million, registered just 50 deaths from Covid and recorded an improvement in life expectancy.

A new vaccine against tuberculosis may also be used as treatment. The vaccine is safe to give to people with tuberculosis disease and strengthens the immune system's ability to attack the bacteria that cause the disease, a new study shows.

Public health mitigation measures such as social distancing, closing training centers and wearing face masks have been used during the Covid-19 pandemic. However, the benefits and harms of these measures are poorly understood.  

This project addresses an urgent issue in global health: the response of African health systems to the Covid-19 pandemic.

Increasing vaccine scepticism makes it more difficult to achieve herd immunity. We therefore need vaccines that protect each individual even better. Gunnveig Grødeland is now initiating the EU project VAXPRED.

Professor John Torgils Vaage leads a study that will examine the effect of COVID-19 vaccination in immunocompromised and transplant patients. The study has received funding from the vaccine coalition CEPI.